Hepatitis C, hemochromatosis and porphyria cutanea tarda;Hepatitis C und hämochromatose bei porphyria cutanea tarda

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 13, 2006, Pages 691-695

  Teubner, A ^a   Richter, M ^a   Schuppan, D ^b   Kostler E ^c   Stöłzel, Ulrich ^a,d  

^a KLINIKUM CHEMNITZ   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; ESTROGEN; PORPHYRIN;

ALCOHOL CONSUMPTION; DISEASE PREDISPOSITION; ENZYME ACTIVITY; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HEMOCHROMATOSIS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; PATHOGENESIS; PORPHYRIA CUTANEA TARDA; PREVALENCE; REMISSION; REVIEW; RISK FACTOR;

HEMOCHROMATOSIS; HEPATITIS C; HUMANS; PORPHYRIA CUTANEA TARDA; PREVALENCE;

EID: 33645712741     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-933718     Document Type: Review

References (51)

1. Bednar B, Kordac V. Changes in the Liver in Porphyria Cutanea Tarda. Cesk Patol 1982; 18: 219-230
2. Beutler E. Penetrance of Haemochromatosis. Gut 2003; 52: 610-611
3. Bonkovsky HL, Banner BF, Lambrecht RW, Rubin RB. Iron in Liver Diseases Other Than Hemochromatosis. Semin Liver Dis 1996; 16: 65-82
4. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N et al. Porphyria Cutanea Tarda, Hepatitis C, and HFE Gene Mutations in North America. Hepatology 1998; 27: 1661-1669
5. Brudieux E, de Ledighen V, Moran MJ et al. Hepatic Porphyrin Concentration and Uroporphyrinogen Decarboxylase Activity in Hepatitis C Virus Infection. J Viral Hepat 2001; 8: 41-47
6. Chlumska A, Chlumsky J, Malina L. Liver Changes in Porphyria Cutanea Tarda Patients Treated With Chloroquine. Br J Dermatol 1980; 102: 261-266
7. Clemmensen O, Thomsen K. Porphyria Cutanea Tarda and Systemic Lupus Erythematosus. Arch Dermatol 1982; 118: 160-162
8. Cortes JM, Oliva H, Paradinas FJ, Hernandez-Guio C. The Pathology of the Liver in Porphyria Cutanea Tarda. Histopathology 1980; 4: 471-485
9. de Verneuil H, Aitken G, Nordmann Y. Familial and Sporadic Porphyria Cutanea: Two Different Diseases. Hum Genet 1978; 44: 145-151
10. Di Padova C, Marchesi L, Cainelli T et al. Effects of Phlebotomy on Urinary Porphyrin Pattern and Liver Histology in Patients With Porphyria Cutanea Tarda. Am J Med Sci 1983; 285: 2-12
11. Doss M. Porphyrin Analysis From Liver Cylinders in Late Cutaneous Porphyria. Klin Wochenschr 1969; 47: 1280-1282
12. Doss M. Porphyrins in Liver and Urine in Porphyria Cutanea Tarda. Dtsch Med Wochenschr 1970; 95: 959-960
13. Doss M. Pathobiochemical Transition of Secondary Coproporphyrinuria to Chronic Hepatic Porphyria in Humans. Klin Wochenschr 1980; 58: 141-148
14. Doss M. Hepatic porphyrias: Pathobiochemical, diagnostic, and therapeutic implications. New York. Grune and Stratton, Popper, H and Schaffner F, eds. Progress in liver diseases. 1982: 573-597
15. Doss M, Meinhof W. Differentiation of Hepatic Porphyrinurias. Dtsch Med Wochenschr 1971; 96: 1006-1013
16. Drobacheff C, Derancourt C, Van Landuyt H et al. Porphyria Cutanea Tarda Associated With Human Immunodeficiency Virus Infection. Eur J Dermatol 1998; 8: 492-496
17. Elder GH. Porphyria Cutanea Tarda. Semin Liver Dis 1998; 18: 67-75
18. Elder GH, Worwood M. Mutations in the Hemochromatosis Gene, Porphyria Cutanea Tarda, and Iron Overload. Hepatology 1998; 27: 289-291
19. Fakan F, Chlumska A, Malina L. Needle-Like Inclusions in Liver Cells Are Specific Diagnostic Signs of Porphyria Cutanea Tarda. Vnitr Lek 1998; 44: 418-422
20. Fargion S, Fracanzani AL, Romano R et al. Genetic Hemochromatosis in Italian Patients With Porphyria Cutanea Tarda: Possible Explanation for Iron Overload. J Hepatol 1996; 24: 564-569
21. Fargion S, Piperno A, Cappellini MD et al. Hepatitis C Virus and Porphyria Cutanea Tarda: Evidence of a Strong Association. Hepatology 1992; 16: 1322-1326
22. Fartoux L, Poujol-Robert A, Guechot J, Wendum D, Poupon R, Serfaty L. Insulin Resistance Is a Cause of Steatosis and Fibrosis Progression in Chronic Hepatitis C. Gut 2005; 54: 1003-1008
23. Fernandez I, Castellano G, De Salamanca RE et al. Porphyria Cutanea Tarda As a Predictor of Poor Response to Interferon Alfa Therapy in Chronic Hepatitis C. Scand J Gastroenterol 2003; 38: 314-319
24. Ferri C, Baicchi U, la Civita L et al. Hepatitis C Virus-Related Autoimmunity in Patients With Porphyria Cutanea Tarda. Eur J Clin Invest 1993; 23: 851-855
25. Fracanzani AL, Fargion S, Stazi MA et al. Association Between Heterozygosity for HFE Gene Mutations and Hepatitis Viruses in Hepatocellular Carcinoma. Blood Cells Mol Dis 2005; 35: 27-32
26. Freesemann A, Frank M, Sieg I, Doss MO. Treatment of Porphyria Cutanea Tarda by the Effect of Chloroquine on the Liver. Skin Pharmacol 1995; 8: 156-161
27. Ippen H. Treatment of Porphyria Cutanea Tarda by Phlebotomy. Semin Hematol 1977; 14: 253-259
28. Kordac V, Semradova M. Treatment of Porphyria Cutanea Tarda With Chloroquine. Br J Dermatol 1974; 90: 95-100
29. Kostler E, Doss MO. Porphyria Cutanea Tarda (Chronic Hepatic Porphyria). Dtsch Med Wochenschr 1995; 120: 1405-1410
30. Kostler E, Gebhardt B, Seebacher C. The HLA System and Porphyria Cutanea Tarda. Dtsch Z Verdau Stoffwechselkr 1984; 44: 95-100
31. Kostler E, Heinicke HJ, Schneider F, Riedel H, Hensel J. Porphyria Cutanea Tarda and Lupus Erythematosus. Z Gesamte Inn Med 1989; 44: 527-529
32. Kostler E, Seebacher C, Riedel H, Kemmer C. Therapeutic and Pathogenetic Aspects of Porphyria Cutanea Tarda. Hautarzt 1986; 37: 210-216
33. Kushner JP, Barbuto AJ, Lee GR. An Inherited Enzymatic Defect in Porphyria Cutanea Tarda: Decreased Uroporphyrinogen Decarboxylase Activity. J Clin Invest 1976; 58: 1089-1097
34. Lefkowitch JH, Grossman ME. Hepatic Pathology in Porphyria Cutanea Tarda. Liver 1983; 3: 19-29
35. Moran MJ, Fontanellas A, Brudieux E et al. Hepatic Uroporphyrinogen Decarboxylase Activity in Porphyria Cutanea Tarda Patients: the Influence of Virus C Infection. Hepatology 1998; 27: 584-589
36. Okano J, Horie Y, Kawasaki H, Kondo M. Interferon Treatment of Porphyria Cutanea Tarda Associated With Chronic Hepatitis Type C. Hepatogastroenterology 1997; 44: 525-528
37. Phillips JD, Jackson LK, Bunting M et al. A Mouse Model of Familial Porphyria Cutanea Tarda. Proc Natl Acad Sci U S A 2001; 98: 259-264
38. Pietrangelo A. Hereditary Hemochromatosis - a New Look at an Old Disease. N Engl J Med 2004; 350: 2383-2397
39. Sampietro M, Fracanzani AL, Corbetta N et al. High Prevalence of Hepatitis C Virus Type 1b in Italian Patients With Porphyria Cutanea Tarda. Ital J Gastroenterol Hepatol 1997; 29: 543-547
40. Sanchez-Tapias JM. Nosocomial Transmission of Hepatitis C Virus. J Hepatol 1999; 31 (Suppl 1); 107-112
41. Schuppan D, Krebs A, Bauer M, Hahn EG. Hepatitis C and Liver Fibrosis. Cell Death Differ 2003; 10 (Suppl 1); S59-S67
42. Shan Y, Lambrecht RW, Bonkovsky HL. Association of Hepatitis C Virus Infection With Serum Iron Status: Analysis of Data From the Third National Health and Nutrition Examination Survey. Clin Infect Dis 2005; 40: 834-841
43. Sheikh MY, Wright RA, Burruss JB. Dramatic Resolution of Skin Lesions Associated With Porphyria Cutanea Tarda After Interferon-Alpha Therapy in a Case of Chronic Hepatitis C. Dig Dis Sci 1998; 43: 529-533
44. Siersema PD, Rademakers LH, Cleton MI et al. The Difference in Liver Pathology Between Sporadic and Familial Forms of Porphyria Cutanea Tarda: the Role of Iron. J Hepatol 1995; 23: 259-267
45. Sinclair PR, Gorman N, Trask HW et al. Uroporphyria Caused by Ethanol in Hfe(-/-) Mice As a Model for Porphyria Cutanea Tarda. Hepatology 2003; 37: 351-358
46. Stolzel U, Kostler E, Koszka C et al. Low Prevalence of Hepatitis C Virus Infection in Porphyria Cutanea Tarda in Germany. Hepatology 1995; 21: 1500-1503
47. Stolzel U, Kostler E, Schuppan D et al. Hemochromatosis (HFE) Gene Mutations and Response to Chloroquine in Porphyria Cutanea Tarda. Arch Dermatol 2003; 139: 309-313
48. Stolzel U, Schuppan D, Tillmann HL et al. Autoimmunity and HCV Infection in Porphyria Cutanea Tarda: a Controlled Study. Cell Mol Biol (Noisy-le-grand) 2002; 48: 43-47
49. Thevenot T, Bachmeyer C, Hammi R, Dumouchel P, Ducamp-Posak I, Cadranel JF. Occurrence of Porphyria Cutanea Tarda During Peginterferon/Ribavirin Therapy for Chronic Viral Hepatitis C. J Hepatol 2005; 42: 607-608
50. Uthemann H, Kotitschke R, Lissner R, Goerz G. Serologic Hepatitis B Markers in Porphyria Cutanea Tarda. Dtsch Med Wochenschr 1980; 105: 1718-1720
51. Valls V, Ena J, Enriquez-De-Salamanca R. Low-Dose Oral Chloroquine in Patients With Porphyria Cutanea Tarda and Low-Moderate Iron Overload. J Dermatol Sci 1994; 7: 169-175